Division of General Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minn.
Division of General Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minn.
J Thorac Cardiovasc Surg. 2014 Feb;147(2):730-6; Discussion 736-7. doi: 10.1016/j.jtcvs.2013.09.063. Epub 2013 Nov 13.
Achalasia has a variety of therapeutic options. We sought to determine the long-term outcome of laparoscopic myotomy in a large group of patients.
We conducted a retrospective record review of 500 patients who underwent laparoscopic myotomy and follow-up with a standardized dysphagia questionnaire.
Between April 1998 and June 2011, 276 men and 224 women underwent a laparoscopic myotomy. Their median age was 51 years (range, 8-89 years). Preoperative symptoms included dysphagia in 472 patients (94.4%), regurgitation in 382 patients (76.4%), heartburn in 203 patients (40.6%), chest pain in 168 (33.6%) patients, and weight loss (median, 10 kg) in 264 patients (52.8%). Prior therapy (dilation in 239, botulinum toxin type A in 135, or myotomy in 30) had been performed in 303 patients (60.6%). Preoperative manometry was available in 413 patients (82.6%) and revealed a median lower esophageal sphincter pressure of 31 mm Hg (range, 0-50 mm Hg), absent peristalsis in 97.6%, and no lower esophageal sphincter relaxation in 75.1%. A laparoscopic myotomy with partial fundoplication (Toupet n = 268, Dor n = 209) was done in 477 patients (95.4%) and myotomy only in 23 patients (4.6%). Conversion to open was necessary in 16 patients (3.2%). There were 52 (10.4%) esophageal perforations-all repaired during the myotomy-and 26 (5.2%) other complications, including bleeding, atrial fibrillation, and pneumonia. There was no operative mortality. Median length of stay was 2 days (range, 1-20 days). Dysphagia questionnaires were returned by 48.2% of patients (241 out of 500) a median of 77.5 months after myotomy (range, 15-176 months). Eighty patients (32.2%) reported no problems with swallowing at the time of the survey. Of 160 patients who had swallowing problems, 40 patients (22.2%) classified the problem as mild or less, 98 patients classified the problem as moderate (70.0%), and 22 patients classified the problem as severe (15.7%). The question concerning frequency of swallowing problems was answered by 160 patients and occurred once a week or less in 70 patients (43.8%), several times a week in 41 patients (25.6%), and at least daily in 49 patients (30.6%). Analysis of all 241 patients who returned questionnaires revealed that 170 out of 241 (70.5%) reported heartburn, 89 out of 241 (36.9%) reported regurgitation, and 159 out of 241 (66.0%) had taken antacids or histamine 2 blockers or proton pump inhibitors within the past 30 days of the survey. The only factor affecting outcome was age; patients older than age 65 years had a better chance of having no difficulty swallowing at follow-up (P = .0174). Sex, prior therapy, Toupet versus Dor, conversion to open, or esophageal mucosal perforation did not affect long-term swallowing outcome.
Laparoscopic myotomy with partial fundoplication is a safe operation. The long-term outcome is extremely effective and approximately one-third of patients have no evidence of persistent symptoms at follow-up. Furthermore, those who have persistent symptoms rarely have severe or very frequent complaints. Patients older than age 65 years tend to have a better outcome.
贲门失弛缓症有多种治疗选择。我们旨在确定在一大组患者中腹腔镜肌切开术的长期结果。
我们对 500 例接受腹腔镜肌切开术和标准化吞咽困难问卷随访的患者进行了回顾性记录分析。
1998 年 4 月至 2011 年 6 月期间,276 名男性和 224 名女性接受了腹腔镜肌切开术。他们的中位年龄为 51 岁(范围,8-89 岁)。术前症状包括吞咽困难 472 例(94.4%),反流 382 例(76.4%),烧心 203 例(40.6%),胸痛 168 例(33.6%)和体重减轻(中位数,10 公斤)264 例(52.8%)。在 303 例患者(60.6%)中已经进行了先前的治疗(扩张术 239 例,肉毒杆菌毒素 A 型 135 例,或肌切开术 30 例)。413 例患者(82.6%)术前有测压,中位食管下括约肌压力为 31mmHg(范围,0-50mmHg),97.6%无蠕动,75.1%无食管下括约肌松弛。477 例患者(95.4%)行腹腔镜肌切开术联合部分胃底折叠术(Toupet n=268,Dor n=209),23 例患者(4.6%)仅行肌切开术。16 例(3.2%)需要转为开放。有 52 例(10.4%)食管穿孔-均在肌切开术中修复-和 26 例(5.2%)其他并发症,包括出血、心房颤动和肺炎。无手术死亡。中位住院时间为 2 天(范围,1-20 天)。术后 77.5 个月(范围,15-176 个月),500 例患者中的 241 例(48.2%)返回了吞咽困难问卷。80 例(32.2%)患者在调查时报告无吞咽问题。在 160 例有吞咽问题的患者中,40 例(22.2%)将问题归类为轻度或更轻,98 例(70.0%)将问题归类为中度,22 例(15.7%)将问题归类为重度。有 160 例患者回答了关于吞咽问题频率的问题,其中 70 例(43.8%)每周或更频繁发生一次,41 例(25.6%)每周几次,49 例(30.6%)每天至少发生一次。对所有 241 例返回问卷的患者进行分析,241 例中有 170 例(70.5%)报告烧心,241 例中有 89 例(36.9%)报告反流,241 例中有 159 例(66.0%)在调查前 30 天内服用过抗酸剂或 H2 受体阻滞剂或质子泵抑制剂。唯一影响结果的因素是年龄;年龄超过 65 岁的患者在随访时更有可能没有吞咽困难(P=0.0174)。性别、先前的治疗、Toupet 与 Dor、转为开放或食管黏膜穿孔均不影响长期吞咽结局。
腹腔镜肌切开术联合部分胃底折叠术是一种安全的手术。长期疗效非常有效,大约三分之一的患者在随访时没有持续的症状。此外,那些持续存在症状的患者很少有严重或非常频繁的抱怨。年龄超过 65 岁的患者倾向于有更好的结果。